MENUNews Archive
Date: 09/23/2013
Recent studies have suggested that an informed patient will be less likely to choose a more-extensive treatment than what the doctor recommends but a recent study by University of Michigan Rogel Cancer Cetner researchers have found that's not necessarily the case.
Date: 09/06/2013
A new study from researchers at the University of Michigan Rogel Cancer Center found that these cells, called myeloid derived suppressor cells, provide a niche where the cancer stem cells survive.
Date: 09/06/2013
Written by Kara Gavin; contact via email or at 734-764-2220.
Date: 08/16/2013
Despite taking a tailored risk assessment tool that factors in family history and personal habits, nearly 20 percent of women did not believe their breast cancer risk, according to a new study from the University of Michigan Rogel Cancer Center.
Date: 08/16/2013
Xofigo, a newly approved treatment for advanced prostate cancer, delivers a powerful punch of radiation directly to tumor cells that have invaded the bone.
Date: 08/03/2013
Results from research at the University of Michigan indicate that if mice have healthy gastrointestinal tract, the chances of surviving high doses of chemotherapy increase.
Date: 08/03/2013
Many of breast cancer patients will receive aggressive treatments that could have little to no effect on their survival.
Date: 07/24/2013
OncoMed Pharmaceuticals, a company started at the University of Michigan in 2004, raised $82 million in an initial public offering.